Edgewell Personal Care Company
EPC · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 2.17B | 880.50M | 182.30M | 99.50M | 1.87 |
| 2023 FY | 2.25B | 940.80M | 227.00M | 114.70M | 2.24 |
| 2024 FY | 2.25B | 955.70M | 199.30M | 98.60M | 1.98 |
| 2025 FY | 2.22B | 924.90M | 96.60M | 25.40M | 0.53 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 3.71B | 2.25B | 188.70M | 1.46B | 1.47B |
| 2023 FY | 3.74B | 2.20B | 216.40M | 1.45B | 1.54B |
| 2024 FY | 3.73B | 2.15B | 209.10M | 1.39B | 1.58B |
| 2025 FY | 3.76B | 2.20B | 225.70M | 1.54B | 1.55B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 102.00M | -56.40M | 45.60M | -32.60M | -290.50M |
| 2023 FY | 216.10M | -49.50M | 166.60M | -31.50M | 27.70M |
| 2024 FY | 231.00M | -56.50M | 174.50M | -30.70M | -7.30M |
| 2025 FY | 118.40M | -77.00M | 41.40M | -29.30M | 16.60M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 1.99B | 3.26B | — | — | — |
| 2023 FY | 1.89B | 3.12B | — | — | — |
| 2024 FY | 1.81B | 2.98B | — | — | — |
| 2025 FY | 967.10M | 2.28B | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2027-09-30 | — | — | — | — | — |
| 2028-09-30 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q3 | 627.20M | 268.50M | 53.70M | 29.10M | 0.61 |
| 2025 Q4 | 537.20M | 208.60M | -36.30M | -30.60M | -0.66 |
| 2026 Q1 | 422.80M | 161.00M | -800.00K | -65.70M | -1.41 |
| 2026 Q2 | 519.50M | 225.60M | 46.10M | -10.60M | -0.23 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q3 | 3.79B | 2.23B | 199.60M | 1.41B | 1.57B |
| 2025 Q4 | 3.76B | 2.20B | 225.70M | 1.54B | 1.55B |
| 2026 Q1 | 3.77B | 2.28B | 223.30M | 1.55B | 1.49B |
| 2026 Q2 | 3.53B | 2.09B | 299.70M | 1.28B | 1.45B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q3 | 114.80M | -15.50M | 99.30M | -7.20M | 29.50M |
| 2025 Q4 | 74.10M | -27.60M | 46.50M | -6.90M | 26.10M |
| 2026 Q1 | -125.90M | -11.60M | -137.50M | -7.40M | -2.40M |
| 2026 Q2 | 54.30M | -14.00M | 40.30M | -7.10M | 76.40M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q3 | 1.12B | 2.33B | — | — | — |
| 2025 Q4 | 946.74M | 2.26B | — | — | — |
| 2026 Q1 | 794.53M | 2.12B | — | — | — |
| 2026 Q2 | 992.31M | 1.97B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |